MRT 50969
Alternative Names: MRT-50969Latest Information Update: 03 Dec 2024
Price :
$50 *
At a glance
- Originator Monte Rosa Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action CCNE1 protein degraders
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours